Tustin, CA - Integrium, LLC announced they will be attending the Redefining Early Stage Investments (RESI) Conference in San Francisco, CA on January 10, 2017. Integrium Executives are consistent attendees of RESI Conference and look to create new relationships within the biotech and investing realm.
RESI has allowed guests to collaborate in ways that help them search for investors, receive funding, build relationships, and learn more about investment trends. The Conference is a key gathering place for early stage life science companies, venture capitalists, investors, and more.
Through a trusted partnership with PoC Capital, Integrium is able to assist Micro Cap, Small Cap, and Privately held Biotechs looking to raise additional financing, by providing new clinical data to create the next bump in valuation. Integrium’s areas of therapeutic focus include Cardiovascular, Metabolic, Renal, Inflammatory, Dermatology, Wound Healing, Gene Therapy, and Orphan Diseases.